院外心脏骤停EMS治疗启动延迟的量化分析
结果显示从呼救到首次除颤(初始可除颤心律)平均11.7分钟,到首次肾上腺素平均约15分钟,到首次抗心律失常药25.1分钟,与已发表试验数据相似。作者认为EMS治疗延迟普遍存在,可能影响临床结局,且Utstein指南与CARES数据库均未要求采集这些时间要素,呼吁监管变革与研究创新。
要点
- 从9-1-1呼救到首次除颤(初始可除颤心律)平均11.7分钟(95%CI 10.1-13.3),到首次肾上腺素初始可除颤15.0分钟、初始不可除颤14.8分钟。
- 从呼救到EMS到达现场(at curb)平均5.0分钟,到接触患者6.7分钟,到首次抗心律失常药25.1分钟。
- 342例成人EMS处置的院外心脏骤停病例的时间间隔与5项已发表临床试验(12954例)数据相似,提示延迟并非单一系统问题。
- Utstein院外指南与CARES数据库均未要求采集这些治疗时间要素,作者认为EMS常未足够快提供治疗以优化结局。
- 作者提出需监管变革与研究,探索无人机递送药物/设备及调度员实时指导等新措施能否改善结局。
适用人群与场景
- 纳入标准为成人、EMS到达前发生的心脏骤停;排除标准原文未明确列出。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为观察性时间间隔分析,样本量342例成人院外心脏骤停,单中心数原文未提及。
- 从9-1-1呼救到各终点平均时间(分钟[95%CI]):派遣0.1[0.05-0.2];到现场路边5.0[4.5,5.5];接触患者6.7[6.1,7.2];首次除颤(初始可除颤)11.7[10.1,13.3];首次肾上腺素初始可除颤15.0[12.8,17.2]、初始不可除颤14.8[13.5,15.9];首次抗心律失常药25.1[22.0,28.2]。
- 上述结果与5项已发表临床试验共12954例受试者的治疗时间数据相似。
证据类型、等级与局限
- 证据类型为观察性研究(时间间隔分析),非随机对照试验。
- 局限:原文未明确说明单中心或多中心、回顾性或前瞻性设计;样本量342例;与已发表试验数据为间接比较而非头对头比较。
对床旁实践的改变
- 提示EMS从呼救到首次除颤和首次肾上腺素的时间延迟普遍存在,急诊/ICU医生在接收院外心脏骤停患者时应关注这些时间间隔对预后的潜在影响。
- 原文指出Utstein指南与CARES数据库未要求采集这些治疗时间要素,提示现有登记数据可能不足以评估治疗及时性。
- 原文未提及对急诊/ICU具体处置流程的改变建议。
指南或共识出处
- 原文引用Utstein院外指南[1]与U.S. Cardiac Arrest Registry to Enhance Survival (CARES)数据库。
- 原文引用5项已发表临床试验的治疗时间数据(具体名称原文未列出)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Time to initial treatment is important in any response to out-of-hospital cardiac arrest (OHCA). The purpose of this paper was to quantify the time delay for providing initial EMS treatments supplemented by comparison with those of other EMS systems conducting clinical trials.
METHODS: Data were collected between 1/1/16-2/15/19. Dispatched, EMS-worked, adult OHCA cases occurring before EMS arrival were included and compared with published treatment time data. Response time and time-to-treatment intervals were profiled in both groups. Time intervals were calculated by subtracting the following timepoints from 9-1-1 call receipt: ambulance in route; at curb; patient contact; first defibrillation; first epinephrine; and first antiarrhythmic.
RESULTS: 342 subjects met study inclusion/exclusion. Mean time intervals (min [95%CI]) from 9-1-1 call receipt to the following EMS endpoints were: dispatch 0.1 [0.05-0.2]; at curb 5.0 [4.5, 5.5]; at patient 6.7 [6.1, 7.2];, first defibrillation initially shockable 11.7 [10.1, 13.3]; first epinephrine (initially shockable 15.0 [12.8, 17.2], initially non-shockable 14.8 [13.5, 15.9]), first antiarrhythmic 25.1 [22.0, 28.2]. These findings were similar to data in 5 published clinical trials involving 12,954 subjects.
CONCLUSIONS: Delay to EMS treatments are common and may affect clinical outcomes. Neither Utstein out-of-hospital guidelines [1] nor U.S. Cardiac Arrest Registry to Enhance Survival (CARES) databases require capture of these elements. EMS is often not providing treatments quickly enough to optimize clinical outcomes. Further regulatory change/research are needed to determine whether OHCA outcome can be improved by novel changes such as enhancing bystander effectiveness through drone-delivered drugs/devices & real-time dispatcher direction on their use.
参考来源
- Ornato JP, Peberdy MA, Siegel CR, et al. Delay to initiation of out-of-hospital cardiac arrest EMS treatments. Am J Emerg Med. 2020. PMID: 33387930. doi:10.1016/j.ajem.2020.12.024
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。